Mechanistic insights into the protective effect of paracetamol against rotenone-induced Parkinson?s disease in rats: Possible role of endocannabinoid system modulation

Parkinson?s disease (PD) is a disabling progressive neurodegenerative disease. So far, PD?s treatment remains symptomatic with no curative effects. Aside from its blatant analgesic and antipyretic efficacy, recent studies highlighted the endowed neuroprotective potentials of paracetamol (PCM). To this end: the present study investigated: (1) Possible protective role of PCM against rotenone-induced PD-like neurotoxicity in rats, and (2) the mechanisms underlying its neuroprotective actions including cannabinoid receptors? modulation. A doseresponse study was conducted using three doses of PCM (25, 50, and 100 mg/kg/day, i.p.) and their effects on body weight changes, spontaneous locomotor activity, rotarod test, tyrosine hydroxylase (TH) and ?-synuclein expression, and striatal dopamine (DA) content were evaluated. Results revealed that PCM (100 mg/kg/day, i.p.) halted PD motor impairment, prevented rotenone-induced weight loss, restored normal histological tissue structure, reversed rotenone-induced reduction in TH expression and striatal DA content, and markedly decreased midbrain and striatal ?-synuclein expression in rotenone-treated rats. Accordingly, PCM (100 mg/kg/ day, i.p.) was selected for further mechanistic investigations, where it ameliorated rotenone-induced oxidative stress, neuro-inflammation, apoptosis, and disturbed cannabinoid receptors? expression. In conclusion, our findings imply a multi-target neuroprotective effect of PCM in PD which could be attributed to its antioxidant, anti-inflammatory and anti-apoptotic activities, in addition to cannabinoid receptors? modulation.

Automated summary

The study demonstrated the neuroprotective effects of paracetamol (PCM) against rotenone-induced Parkinson's disease (PD) symptoms. PCM alleviated motor impairments, prevented weight loss, restored tissue structure, and reversed reduction in dopamine content. Additionally, PCM exhibited antioxidant, anti-inflammatory, anti-apoptotic activities, and modulated cannabinoid receptors to protect against PD.